vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)- has been researched along with 15-keto-13,14-dihydroprostaglandin f2alpha in 1 studies
| Studies (vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)-) | Trials (vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)-) | Recent Studies (post-2010) (vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)-) | Studies (15-keto-13,14-dihydroprostaglandin f2alpha) | Trials (15-keto-13,14-dihydroprostaglandin f2alpha) | Recent Studies (post-2010) (15-keto-13,14-dihydroprostaglandin f2alpha) |
|---|---|---|---|---|---|
| 43 | 0 | 4 | 678 | 46 | 50 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitchell, M; Nathanielsz, PW; Owiny, JR | 1 |
1 other study(ies) available for vasotocin, 1-(beta-mercapto-(beta, beta-cyclopentamethylene)propionic acid)-tyr(om3)(2)-orn(8)- and 15-keto-13,14-dihydroprostaglandin f2alpha
| Article | Year |
|---|---|
Effect of 48-hour infusion of the synthetic oxytocin antagonist, [1-beta-mercapto(beta-(CH2)5)1(OMe)Tyr2,Orn8]-oxytocin, on myometrial activity of pregnant sheep at 139-140 days of gestation.
Topics: Animals; Dinoprost; Female; Myometrium; Oxytocin; Pregnancy; Sheep; Uterine Contraction; Uterus; Veins | 1992 |